Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALFRED Y SUN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1922279058
CMS profile
1386823
Location
CUPERTINO, CA

General Payments · PY2018–2023

$3,462.48

  • Reported across 68 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$529.68

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $529.68 14

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Otsuka America Pharmaceutical, Inc. $136.73 2
Alkermes, Inc. $126.46 3
Axsome Therapeutics, Inc. $103.32 1
ABBVIE INC. $83.20 4
Indivior Inc. $36.92 2
Teva Pharmaceuticals USA, Inc. $25.18 1
ITI, Inc. $17.87 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $715.77 11
PY2019 $1,431.74 17
PY2020 $113.79 7
PY2021 $164.19 8
PY2022 $507.31 11
PY2023 $529.68 14

Payment records · PY2023 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.89 02/10/2023 Food and Beverage Undisputed 01/23/2026 1013704899 CMS
ABBVIE INC. $20.11 04/28/2023 Food and Beverage Undisputed 01/23/2026 1013704905 CMS
ABBVIE INC. $17.77 08/29/2023 Food and Beverage Undisputed 01/23/2026 1013704911 CMS
ABBVIE INC. $18.43 11/01/2023 Food and Beverage Undisputed 01/23/2026 1013704917 CMS
Alkermes, Inc. $14.53 01/31/2023 Food and Beverage Undisputed 01/23/2026 1023986585 CMS
Alkermes, Inc. $96.24 03/16/2023 Food and Beverage Undisputed 01/23/2026 1023986587 CMS
Alkermes, Inc. $15.69 05/10/2023 Food and Beverage Undisputed 01/23/2026 1023986589 CMS
Axsome Therapeutics, Inc. $103.32 07/27/2023 Food and Beverage Undisputed 01/23/2026 1056123751 CMS
Indivior Inc. $17.84 02/14/2023 Food and Beverage Undisputed 01/23/2026 1034270085 CMS
Indivior Inc. $19.08 07/25/2023 Food and Beverage Undisputed 01/23/2026 1034270093 CMS
ITI, Inc. $17.87 08/09/2023 Food and Beverage Undisputed 01/23/2026 1040716019 CMS
Otsuka America Pharmaceutical, Inc. $13.06 08/09/2023 Food and Beverage Undisputed 01/23/2026 1014852879 CMS
Otsuka America Pharmaceutical, Inc. $123.67 08/24/2023 Food and Beverage Undisputed 01/23/2026 1014852891 CMS
Teva Pharmaceuticals USA, Inc. $25.18 06/02/2023 Food and Beverage Undisputed 01/23/2026 1056741825 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.